
SPONSORED CONTENT Please join on us April 22nd at 1:00 p.m. EST for the third installment of RxParadigm’s 340B Clearinghouse […]
SPONSORED CONTENT Please join on us April 22nd at 1:00 p.m. EST for the third installment of RxParadigm’s 340B Clearinghouse […]
SPONSORED CONTENT It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an […]
SPONSORED CONTENT At the 340B Coalition winter conference in February, two major topics were impossible to ignore: the growing interest […]
SPONSORED CONTENT W. Edwards Deming is a renowned statistician and expert in quality management. He is often quoted as saying, […]
SPONSORED CONTENT The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims […]
SPONSORED CONTENT The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is […]
SPONSORED CONTENT A HRSA audit is not a question of if but when. Therefore, it is crucial for covered entities […]
SPONSORED CONTENT Let me start by saying that I have been to the 340B Coalition conferences since 2012, and every […]
SPONSORED CONTENT The 340B program serves as a critical resource for hospitals and other safety net providers striving to provide […]
SPONSORED CONTENT The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. […]
*Sign up for news summaries and alerts from 340B Report